Literature DB >> 23325471

Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?

Alan T Remaley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23325471      PMCID： PMC3864680          DOI： 10.1161/ATVBAHA.112.300921

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  17 in total

1.  A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.

Authors:  S S Deeb; K Takata; R L Peng; G Kajiyama; J J Albers
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

2.  5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Authors:  Marcelo J A Amar; Wilissa D'Souza; Scott Turner; Stephen Demosky; Denis Sviridov; John Stonik; Jayraz Luchoomun; Jason Voogt; Marc Hellerstein; Dmitri Sviridov; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-19       Impact factor: 4.030

3.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.

Authors:  A T Remaley; J A Stonik; S J Demosky; E B Neufeld; A V Bocharov; T G Vishnyakova; T L Eggerman; A P Patterson; N J Duverger; S Santamarina-Fojo; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

4.  LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.

Authors:  M E Brousseau; R D Kauffman; E E Herderick; S J Demosky; W Evans; S Marcovina; S Santamarina-Fojo; H B Brewer; J M Hoeg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

5.  Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function.

Authors:  Junji Yamashita; Chiaki Iwamura; Tetsuya Sasaki; Kunitoshi Mitsumori; Kazutoshi Ohshima; Kaori Hada; Naoko Hara; Munehisa Takahashi; Yoshiaki Kaneshiro; Hitoshi Tanaka; Kenji Kaneko; Toshinori Nakayama
Journal:  J Immunol       Date:  2011-02-07       Impact factor: 5.422

6.  RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.

Authors:  Dana Bailey; Ravi Jahagirdar; Allan Gordon; Anouar Hafiane; Steven Campbell; Safia Chatur; Gregory S Wagner; Henrik C Hansen; Fabrizio S Chiacchia; Jan Johansson; Larbi Krimbou; Norman C W Wong; Jacques Genest
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 7.  High density lipoprotein: it's not just about lipid transport anymore.

Authors:  Scott M Gordon; Susanna Hofmann; David S Askew; W Sean Davidson
Journal:  Trends Endocrinol Metab       Date:  2010-11-08       Impact factor: 12.015

8.  The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population.

Authors:  Jing Xiao; Fan Zhang; Steven Wiltshire; Joseph Hung; Michelle Jennens; John P Beilby; Peter L Thompson; Brendan M McQuillan; Pamela A McCaskie; Kim W Carter; Lyle J Palmer; Brenda L Powell
Journal:  Atherosclerosis       Date:  2008-01-07       Impact factor: 5.162

Review 9.  HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.

Authors:  Alan T Remaley; Marcelo Amar; Dmitri Sviridov
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-10

10.  Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.

Authors:  W J Johnson; E P Kilsdonk; A van Tol; M C Phillips; G H Rothblat
Journal:  J Lipid Res       Date:  1991-12       Impact factor: 5.922
View more
  7 in total

1.  Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.

Authors:  Kelly Fellows; Tomas Uher; Richard W Browne; Bianca Weinstock-Guttman; Dana Horakova; Helena Posova; Manuela Vaneckova; Zdenek Seidl; Jan Krasensky; Michaela Tyblova; Eva Havrdova; Robert Zivadinov; Murali Ramanathan
Journal:  J Lipid Res       Date:  2015-08-04       Impact factor: 5.922

2.  Setting the course for apoAII: a port in sight?

Authors:  Henry J Pownall; Baiba K Gillard; Antonio M Gotto
Journal:  Clin Lipidol       Date:  2013-10

3.  Transcriptome analysis to characterize the genes related to gonad growth and fatty acid metabolism in the sea urchin Strongylocentrotus intermedius.

Authors:  Heng Wang; Jun Ding; Siyu Ding; Yaqing Chang
Journal:  Genes Genomics       Date:  2019-09-04       Impact factor: 1.839

4.  Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma.

Authors:  Richard Wagner; Julia Dittrich; Joachim Thiery; Uta Ceglarek; Ralph Burkhardt
Journal:  J Lipid Res       Date:  2019-02-05       Impact factor: 5.922

5.  Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia.

Authors:  Anastasiia S Boiko; Irina A Mednova; Elena G Kornetova; Arkadiy V Semke; Nikolay A Bokhan; Anton J M Loonen; Svetlana A Ivanova
Journal:  Heliyon       Date:  2019-07-03

6.  Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction.

Authors:  Takashi Hisamatsu
Journal:  J Atheroscler Thromb       Date:  2020-11-13       Impact factor: 4.928

7.  Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study.

Authors:  Tomomi Kihara; Kazumasa Yamagishi; Kazufumi Honda; Ai Ikeda; Hiroshi Yatsuya; Isao Saito; Yoshihiro Kokubo; Taiki Yamaji; Taichi Shimazu; Norie Sawada; Motoki Iwasaki; Hiroyasu Iso; Shoichiro Tsugane
Journal:  J Atheroscler Thromb       Date:  2020-08-29       Impact factor: 4.928
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.